Literature DB >> 10680124

[Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. DRECE study group].

J A Gómez-Gerique1, J A Gutiérrez-Fuentes, M T Montoya, A Porres, A Rueda, A Avellaneda, M A Rubio.   

Abstract

BACKGROUND: In Spain the mortality rate due to cardiovascular disease (CVD) is relatively low compared to that of other developed countries. Until now few epidemiological studies have been performed among the global Spanish population to evaluate a relation between CVD risk factors and the lipid profile that could justify our privileged situation. For, this reason, the DRECE study was designed to know the situation at present in Spain respect to the risk of suffering from CVD in particular, the lipid profile. POPULATION AND METHODS: This study included 4,787 subjects (2,324 males and 2,463 females) with an age ranging from 5-60 years, representative of the total Spanish population with these characteristics during the period from 1992 to 1994. Medical history was made for all participants, who also underwent a physical examination. The following parameters were determined: total cholesterol (TC), triglycerides, high-density lipoproteins cholesterol HDLc, cholesterol transported by low-density lipoproteins, LDLc (estimated by the Friedewald's formula), apolipoprotein AI and apoliprotein B (immunoturbidimetry).
RESULTS: The results obtained and expressed in mean (SD) show that, although the population has total cholesterol concentrations (190.1 [42.4] and 192.8 [44.8] mg/dl for females and males, respectively) and LDLc (113.9 [37.9] and 117.5 [38.1] mg/dl for females and males, respectively) with values as high as those found in developed countries, the HDLc concentrations (58.6 [13.2] and 51.5 [13.4] mg/dl for women and men, respectively) are also increased and this could be the reason why the mortality rate in Spain caused by CVD is lower than in other countries.
CONCLUSIONS: The finding of high HDLc levels and their antiatherogenic role could justify that, at best in part, the rate mortality in Spain is lower than in other developed countries.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10680124

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  8 in total

1.  A moderate intake of phytosterols from habitual diet affects cholesterol metabolism.

Authors:  T Sanclemente; I Marques-Lopes; M Fajó-Pascual; M Cofán; E Jarauta; E Ros; J Puzo; A L García-Otín
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

2.  Hyperlipoproteinaemia(a) is a common cause of autosomal dominant hypercholesterolaemia.

Authors:  E Meriño-Ibarra; J Puzo; E Jarauta; A Cenarro; D Recalde; A L García-Otín; E Ros; E Martorell; X Pintó; M Franco; D Zambón; A Brea; M Pocoví; F Civeira
Journal:  J Inherit Metab Dis       Date:  2007-10-20       Impact factor: 4.982

3.  Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia.

Authors:  Ana Margarida Medeiros; Ana Catarina Alves; Pedro Aguiar; Mafalda Bourbon
Journal:  J Lipid Res       Date:  2014-03-13       Impact factor: 5.922

4.  The importance of an integrated analysis of clinical, molecular, and functional data for the genetic diagnosis of familial hypercholesterolemia.

Authors:  Asier Benito-Vicente; Ana Catarina Alves; Aitor Etxebarria; Ana Medeiros Medeiros; Cesar Martin; Mafalda Bourbon
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

5.  Serum lipid profile in subjects with traumatic spinal cord injury.

Authors:  Martin Laclaustra; Elizabeth Louise Maayken Van Den Berg; Yamilée Hurtado-Roca; Juan Manuel Castellote
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

6.  Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment.

Authors:  Inka Miñambres; Jose Luis Sánchez-Quesada; Joan Sánchez-Hernández; Jose Rodríguez; Alberto de Leiva; Antonio Pérez
Journal:  Diabetol Metab Syndr       Date:  2014-01-22       Impact factor: 3.320

7.  A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia.

Authors:  Isabel De Castro-Orós; Javier Pérez-López; Rocio Mateo-Gallego; Soraya Rebollar; Marta Ledesma; Montserrat León; Montserrat Cofán; Jose A Casasnovas; Emilio Ros; Jose C Rodríguez-Rey; Fernando Civeira; Miguel Pocoví
Journal:  BMC Med Genomics       Date:  2014-04-07       Impact factor: 3.063

8.  Association between non-cholesterol sterol concentrations and Achilles tendon thickness in patients with genetic familial hypercholesterolemia.

Authors:  Lucía Baila-Rueda; Itziar Lamiquiz-Moneo; Estíbaliz Jarauta; Rocío Mateo-Gallego; Sofía Perez-Calahorra; Victoria Marco-Benedí; Ana M Bea; Ana Cenarro; Fernando Civeira
Journal:  J Transl Med       Date:  2018-01-15       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.